Skip to content
Sunday, November 15, 2026
London ACE Office

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Deal Due to Data Apprehensions

Health funding illustration
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has declined a substantial US health deal valued at $367m (£272m) over five years over the United States' request for sensitive data.

The decision came to light after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesperson has since clarified that the US was requesting biological samples for scientific study and profit while was unwilling to share the benefits from future treatments.

"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for further dialogue to secure a agreement suitable to both sides so the country's vital HIV treatment initiative can proceed.

Wider Background

Zimbabwe's decision follows a comparable situation in Kenya, where a high court halted a related deal with the US after legal challenges were filed about the safety of citizens' medical information.

After returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.

According to statements, Sixteen African countries have to date agreed to these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through American-funded initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.

"Put simply, our country would supply the basic resources for medical research with no certainty that the end products would be accessible to our people if a new health crisis emerge."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures already set up via the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.

"This mechanism is intended to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage ongoing discussions with our American counterparts on how subsequent co-operation could be arranged in a way that respects the independence and dignity of each country."

Health Experts Response

Medical experts said it acknowledged the official position, but urged that negotiations should continue given that a large portion of the country's Aids initiatives relied on foreign aid.

"In cases where specific concerns exist, such as those involving information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it said.

The situation underscores the ongoing tensions between accepting crucial foreign assistance and safeguarding a country's data in an ever more data-driven world.

SM
About the author

Sharon May

Jonathan is a business consultant with over 15 years of experience in corporate services and workspace solutions.

London ACE Office

Type to search articles.